 |
|
Anti– -Fodrin Antibodies in Sjögren Syndrome and Lupus Erythematosus
Takahiro Watanabe, MD, PhD;
Tetsuya Tsuchida, MD, PhD;
Naoko Kanda, MD, PhD;
Katsunori Mori, MD;
Yoshio Hayashi, MD, PhD;
Kunihiko Tamaki, MD
Arch Dermatol. 1999;135:535-539.
Objectives To investigate the prevalence of anti– -fodrin antibody in patients with Sjögren syndrome (SS), lupus erythematosus (LE), or both and the association of this antibody with other clinical manifestations.
Design A study of screening and diagnostic tests. Mean follow-up was 152 months (range, 4-572 months).
Setting A university hospital associated with a research laboratory in Tokyo, Japan.
Patients Nine patients with primary SS, 15 patients with SS secondary to LE, and 44 patients with LE alone.
Main Outcome Measures Frequencies of clinical and laboratory findings, including anti–-fodrin antibody.
Results Anti–-fodrin antibody was more commonly detected in patients with primary (7/9; P<.001) and secondary (9/15; P<.001) SS than in those with LE alone (3/44). When patients with primary and secondary SS were combined and compared with those with LE alone, the sensitivity of anti–-fodrin antibody was 67%, specificity was 93%, and both positive and negative predictive values were 84%. The presence of anti–-fodrin antibody was associated with pernio, hyperglobulinemia, rheumatoid factor positivity, and the presence of anti–SS-B (La) antibody (P<.01) but not with annular erythema, photosensitivity, vasculitis, or renal disorder.
Conclusions Although anti–-fodrin antibody was detected in patients with SS and in those with LE, it seemed to be more valuable for the diagnosis of SS than was anti–SS-A (Ro) because anti–-fodrin was much less prevalent in patients with LE alone. It may be possible to consider this novel autoantibody as pathophysiologically associated with some extraglandular manifestations characteristically seen in patients with SS.
From the Department of Dermatology, Faculty of Medicine, University of Tokyo, Tokyo (Drs Watanabe, Kanda, Mori, and Tamaki); the Department of Dermatology, Saitama Medical School, Saitama (Dr Tsuchida); and the Department of Pathology, Tokushima University School of Dentistry, Tokushima (Dr Hayashi), Japan.
RELATED ARTICLE
Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 1999;135(5):617-618.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Lack of CCR5 on dendritic cells promotes a proinflammatory environment in submandibular glands of the NOD mouse
Wildenberg et al.
J. Leukoc. Biol. 2008;83:1194-1200.
ABSTRACT
| FULL TEXT
Primary Sjogren's syndrome: current and emergent aetiopathogenic concepts
Ramos-Casals and Font
Rheumatology (Oxford) 2005;44:1354-1367.
FULL TEXT
Anti-{alpha}-fodrin autoantibodies are not useful diagnostic markers of primary Sjogren's syndrome
Sordet et al.
Ann Rheum Dis 2005;64:1244-1245.
FULL TEXT
Molecular Analysis of the Human Autoantibody Response to {alpha}-Fodrin in Sjogren's Syndrome Reveals Novel Apoptosis-Induced Specificity
Maruyama et al.
Am. J. Pathol. 2004;165:53-61.
ABSTRACT
| FULL TEXT
Autoantibodies to the Amino-Terminal Fragment of {beta}-Fodrin Expressed in Glandular Epithelial Cells in Patients with Sjogren's Syndrome
Kuwana et al.
J. Immunol. 2001;167:5449-5456.
ABSTRACT
| FULL TEXT
|
